Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis. [electronic resource]
Producer: 20200421Description: 1568-1577 p. digitalISSN:- 1745-7254
- Animals
- Antineoplastic Agents -- therapeutic use
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cyanoacrylates -- therapeutic use
- Drug Repositioning
- Drug Synergism
- Female
- HEK293 Cells
- Humans
- Mebendazole -- therapeutic use
- Mice, Inbred BALB C
- Mice, Nude
- Multiple Myeloma -- drug therapy
- Proof of Concept Study
- Protein Binding -- drug effects
- Proto-Oncogene Proteins c-maf -- chemistry
- Pyridines -- therapeutic use
- Ubiquitin-Specific Proteases -- chemistry
- Ubiquitination -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.